Bryon Quick
Critical Care Medicine · Oakland, CANPI 1639257413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Johnson & Johnson accounts for 64.7% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for critical care medicine clinicians in CA, where the typical reported total is $352.
Across 10 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$134
- Pulmonx Corporation$57
- Intuitive Surgical$16
Across 24 payments — averaging $24,728 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$591K
- AbbVie$1K
- Vivus LLC$854
What the payments were for
- Food & beverage$208100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 6 | $134 |
| Pulmonx Corporation | 3 | $57 |
| Intuitive Surgical | 1 | $16 |
How this compares
$208 in reported general payments places this provider in the 35th percentile of 715 critical care medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrikaftaElexacaftor/Tezacaftor/Ivacaft | 75 | $2,005,329 |
| SymdekoTezacaftor/Ivacaftor | 14 | $350,339 |
| CaystonAztreonam Lysine | 14 | $169,925 |
| ZenpepLipase/Protease/Amylase | 19 | $100,722 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 19 | $17,314 |
| Spiriva RespimatTiotropium Bromide | 23 | $17,195 |
| Wixela InhubFluticasone Propion/Salmeterol | 36 | $6,455 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $1,533 |
| BreynaBudesonide/Formoterol Fumarate | 12 | $1,512 |
| Azithromycin | 18 | $426 |
| Fluticasone Propionate | 12 | $229 |
| Prednisone | 15 | $215 |
| Clonazepam | 11 | $76 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Oakland
- Sachin GuptaOakland$86K
- Cedric Franklin RutlandRiverside$3.2M
- Chinh PhanSacramento$467K
- Timothy AlbertsonSacramento$418K
- Stephen ChenMonterey Park$394K
- Bassam YaghmourOrange$376K
- Xuanha WhiteSan Diego$343K
- Ken YonedaSacramento$173K
- Praveen AkuthotaSan Diego$169K
- Ivan ChengSan Francisco$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.